StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$13.92−2.76 (-16.55%)

Close on Nov 17, 2026Market cap $1.01BP/E –Yield –

Omeros price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Omeros's price to sales ratio was 5.3× on Jan 31, 2022, against 12.4× a year earlier. Over the last 5 years it ranged from 5.3× to 32.5×, with a median of 13.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 20225.3×−0.4
2021Dec 31, 20215.6×−3.5
2020Dec 31, 20209.1×+2.2
2019Dec 31, 20197.0×−18.3
2018Dec 31, 201825.3×+10.7
2017Dec 29, 201714.6×+2.5
2016Dec 30, 201612.0×−73.1
2015Dec 31, 201585.2×−149.8
2014Apr 30, 2014234.9×+123.1
2013Dec 31, 2013111.8×+87.7
2012Dec 31, 201224.1×+3.8
2011Dec 30, 201120.2×–

More Omeros figures

See a number that looks wrong?